<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05798676</url>
  </required_header>
  <id_info>
    <org_study_id>L2022</org_study_id>
    <nct_id>NCT05798676</nct_id>
  </id_info>
  <brief_title>Maternal Characteristics Associated With Child Growth and Adiposity</brief_title>
  <official_title>Maternal Characteristics Associated With Child Growth and Adiposity. Search for Nutrigenomic Biomarkers in Peripheral Blood</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Instituto de Desarrollo e Investigaciones Pediátricas Prof. Dr. Fernando E. Viteri</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Instituto de Desarrollo e Investigaciones Pediátricas Prof. Dr. Fernando E. Viteri</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this observational study is to investigate the concentrations of leptin, insulin&#xD;
      and cortisol in plasma and breast milk and their relationship with eating behavior, growth,&#xD;
      adiposity and with the levels of these hormones in infants, comparing mothers with normal&#xD;
      weight and with pre-pregnancy overweight/obesity. The main question[s] it aims to answer are:&#xD;
&#xD;
        -  Are maternal hormones associated with child growth and adiposity&#xD;
&#xD;
        -  Are maternal hormone receptors associated with child growth and adiposity&#xD;
&#xD;
        -  Are infant hormones and their receptors associated with child growth and adiposity&#xD;
           Participants will provide milk and blood samples. Researchers will compare mothers with&#xD;
           normal weight and with pre-pregnancy overweight/obesity to see if there are differences&#xD;
           in child growth and adiposity .&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 2, 2019</start_date>
  <completion_date type="Anticipated">March 2026</completion_date>
  <primary_completion_date type="Anticipated">March 2025</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>infant weight</measure>
    <time_frame>from birth to 2 years old</time_frame>
    <description>weight in kilograms</description>
  </primary_outcome>
  <primary_outcome>
    <measure>infant height</measure>
    <time_frame>from birth to 2 years old</time_frame>
    <description>height in centimeters</description>
  </primary_outcome>
  <primary_outcome>
    <measure>infant body mass index (BMI)</measure>
    <time_frame>from birth to 2 years old</time_frame>
    <description>weight and height will be combined to report BMI in kg/m^2</description>
  </primary_outcome>
  <primary_outcome>
    <measure>infant upper arm circumference</measure>
    <time_frame>from birth to 2 years old</time_frame>
    <description>upper arm circumference in centimeters</description>
  </primary_outcome>
  <primary_outcome>
    <measure>infant skinfold thickness</measure>
    <time_frame>from birth to 2 years old</time_frame>
    <description>skinfold thickness in centimeters</description>
  </primary_outcome>
  <primary_outcome>
    <measure>infant blood leptin concentration</measure>
    <time_frame>six months old</time_frame>
    <description>blood leptin concentration (ng/ml)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>infant blood cortisol concentration</measure>
    <time_frame>six months old</time_frame>
    <description>blood cortisol concentration (ug%)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>infant saliva cortisol concentration</measure>
    <time_frame>six months old</time_frame>
    <description>saliva cortisol (ug%)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>infant blood insulin concentration</measure>
    <time_frame>six months old</time_frame>
    <description>blood insulin concentration (uU/ml)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>infant insulin receptor gene expression in peripheral blood mononuclear cells</measure>
    <time_frame>six months old</time_frame>
    <description>insulin receptor gene expression in peripheral blood mononuclear cells (relative expression)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>infant leptin receptor gene expression in peripheral blood mononuclear cells</measure>
    <time_frame>six months old</time_frame>
    <description>leptin receptor gene expression in peripheral blood mononuclear cells (relative expression)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>infant glucocorticoid receptor gene expression in peripheral blood mononuclear cells</measure>
    <time_frame>six months old</time_frame>
    <description>glucocorticoid receptor gene expression in peripheral blood mononuclear cells (relative expression)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>maternal blood leptin concentration</measure>
    <time_frame>15 days, three and six months postpartum</time_frame>
    <description>blood leptin concentration (ng/ml)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>maternal milk leptin concentration</measure>
    <time_frame>15 days, three and six months postpartum</time_frame>
    <description>milk leptin concentration (ng/ml)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>maternal blood insulin concentration</measure>
    <time_frame>15 days, three and six months postpartum</time_frame>
    <description>blood insulin concentration (uU/ml)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>maternal milk insulin concentration</measure>
    <time_frame>15 days, three and six months postpartum</time_frame>
    <description>milk insulin concentration (uU/ml)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>maternal blood cortisol concentration</measure>
    <time_frame>15 days, three and six months postpartum</time_frame>
    <description>blood cortisol concentration (ug%)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>maternal milk cortisol concentration</measure>
    <time_frame>15 days, three and six months postpartum</time_frame>
    <description>milk cortisol concentration (ug%)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>maternal insulin receptor gene expression in peripheral blood mononuclear cells</measure>
    <time_frame>15 days, three and six months postpartum</time_frame>
    <description>insulin receptor gene expression in peripheral blood mononuclear cells (relative expression)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>maternal leptin receptor gene expression in peripheral blood mononuclear cells</measure>
    <time_frame>15 days, three and six months postpartum</time_frame>
    <description>leptin receptor gene expression in peripheral blood mononuclear cells (relative expression)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>maternal glucocorticoid receptor gene expression in peripheral blood mononuclear cells</measure>
    <time_frame>15 days, three and six months postpartum</time_frame>
    <description>glucocorticoid receptor gene expression in peripheral blood mononuclear cells (relative expression)</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Obesity</condition>
  <condition>Obesity, Infant</condition>
  <arm_group>
    <arm_group_label>mothers with pre-pregnancy normal weight and their infants</arm_group_label>
    <description>mothers with pre-pregnancy normal weight according to World Health Organization will provide blood and milk samples</description>
  </arm_group>
  <arm_group>
    <arm_group_label>mothers with pre-pregnancy overweight or obesity and their infants</arm_group_label>
    <description>mothers with pre-pregnancy overweight or obesity according to World Health Organization will provide blood and milk samples</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>overweight/obesity</intervention_name>
    <description>the consequences of maternal pregestational overweight/obesity on infant´s growth and adiposity will be studied</description>
    <arm_group_label>mothers with pre-pregnancy overweight or obesity and their infants</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      blood and milk&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Lactating women with pre-pregnancy normal weight and overweight or obesity recruited at the&#xD;
        Mother and Healthy Children Outpatient Service, Instituto de Desarrollo e Investigaciones&#xD;
        Pediátricas (IDIP), HIAEP &quot;Sor María Ludovica&quot;, La Plata, Argentina.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Lactating women with pre-pregnancy normal weight and overweight or obesity as&#xD;
             described by the World Health Organization.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Diabetes (Type I or II or gestational)&#xD;
&#xD;
          -  Multiple pregnancy&#xD;
&#xD;
          -  Hypertensive disorders during pregnancy&#xD;
&#xD;
          -  Delivery of pre-term infant (&lt;37 weeks).&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maria F Andreoli, BsC</last_name>
    <role>Principal Investigator</role>
    <affiliation>Instituto de Desarrollo e Investigaciones Pediátricas Prof. Dr. Fernando E. Viteri</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Maria F Andreoli, PhD</last_name>
    <phone>54 221 4535901</phone>
    <phone_ext>1767</phone_ext>
    <email>mfandreoli@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Instituto de Desarrollo e Investigaciones Pediátricas Prof. Dr. Fernando E. Viteri</name>
      <address>
        <city>La Plata</city>
        <state>Buenos Aires</state>
        <zip>1900</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria F Andreoli, PhD</last_name>
      <phone>54 221 4535901</phone>
      <phone_ext>1767</phone_ext>
      <email>mfandreoli@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Ana Kruger, BsC</last_name>
      <phone>54 221 4535901</phone>
      <phone_ext>1767</phone_ext>
      <email>krugluzana@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Argentina</country>
  </location_countries>
  <verification_date>February 2023</verification_date>
  <study_first_submitted>February 23, 2023</study_first_submitted>
  <study_first_submitted_qc>March 22, 2023</study_first_submitted_qc>
  <study_first_posted type="Actual">April 4, 2023</study_first_posted>
  <last_update_submitted>March 22, 2023</last_update_submitted>
  <last_update_submitted_qc>March 22, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">April 4, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Pediatric Obesity</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

